Literature DB >> 1626762

High prevalence of celiac disease in healthy adults revealed by antigliadin antibodies.

E Grodzinsky1, L Franzen, J Hed, M Ström.   

Abstract

Sera from 1866 healthy blood donors and from 40 untreated adults with celiac disease were analyzed using a micro-ELISA assay. Blood donors with IgA antigliadin activity greater than 40 units corresponding to the 96.8th percentile and IgG antigliadin activity greater than 20 units corresponding to the 91.3rd percentile were selected for further investigation and jejunal biopsy. Seven of 49 blood donors with high IgA antigliadin activity showed mucosal lesions typical for celiac disease. None of the donors with high IgG antigliadin activity (35 subjects) but without high IgA activity had such mucosal lesions. A prevalence of celiac disease of at least 1/256 was observed in the donor group. There were significant age-group differences in IgA antigliadin activity. In the present study, a high IgA antigliadin activity had a positive predictive value between 18% and 25% in individuals without symptoms indicative of celiac disease depending on the way the cut-off points were chosen. In contrast, the positive predictive value of high IgG antigliadin activity alone was estimated to be 0%.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1626762

Source DB:  PubMed          Journal:  Ann Allergy        ISSN: 0003-4738


  17 in total

1.  Contribution of the MHC region to the familial risk of coeliac disease.

Authors:  S Bevan; S Popat; C P Braegger; A Busch; D O'Donoghue; K Falth-Magnusson; A Ferguson; A Godkin; L Hogberg; G Holmes; K B Hosie; P D Howdle; H Jenkins; D Jewell; S Johnston; N P Kennedy; G Kerr; P Kumar; R F Logan; A H Love; M Marsh; C J Mulder; K Sjoberg; L Stenhammer; J Walker-Smith; A M Marossy; R S Houlston
Journal:  J Med Genet       Date:  1999-09       Impact factor: 6.318

Review 2.  Pathogenesis of coeliac disease: implications for treatment.

Authors:  J S Fraser; P J Ciclitira
Journal:  World J Gastroenterol       Date:  2001-12       Impact factor: 5.742

3.  High antigliadin IgG titers in laboratory rabbits fed a wheat-containing diet: a model for celiac disease?

Authors:  John B March
Journal:  Dig Dis Sci       Date:  2003-03       Impact factor: 3.199

4.  Prevalence and demographic characteristics of celiac disease among blood donors in Ribeirão Preto, State of São Paulo, Brazil.

Authors:  Suzeidi Bernardo Castanheira Melo; Maria Inez Machado Fernandes; Luiz Cesar Peres; Luiz Ernesto Almeida Troncon; Livia Carvalho Galvão
Journal:  Dig Dis Sci       Date:  2006-06-07       Impact factor: 3.199

5.  An algorithm for family screening for coeliac disease.

Authors:  Jocelyn-S Fraser; Alistair-L King; H-Julia Ellis; Simon-J Moodie; Ingvar Bjarnason; Jill Swift; Paul-J Ciclitira
Journal:  World J Gastroenterol       Date:  2006-12-28       Impact factor: 5.742

6.  New automated immunoassay measuring immunoglobulin A antigliadin antibodies for prediction of celiac disease in childhood.

Authors:  E Grodzinsky; A Ivarsson; P Juto; P Olcén; K Fälth-Magnusson; L A Persson ; O Hernell
Journal:  Clin Diagn Lab Immunol       Date:  2001-05

7.  Prospective study of body mass index in patients with coeliac disease.

Authors:  W Dickey; S Bodkin
Journal:  BMJ       Date:  1998-11-07

8.  Effectiveness of antigliadin antibodies as a screening test for celiac disease in children.

Authors:  L J Chartrand; J Agulnik; T Vanounou; P A Russo; P Baehler; E G Seidman
Journal:  CMAJ       Date:  1997-09-01       Impact factor: 8.262

9.  Prevalence of celiac disease in an urban area of Brazil with predominantly European ancestry.

Authors:  Maria Angélica G Pereira; Carmen L Ortiz-Agostinho; Iêda Nishitokukado; Maria-N Sato; Adérson O M C Damião; Marília L Alencar; Clarice P Abrantes-Lemos; Eduardo L R Cançado; Thales de Brito; Sérgio O Ioshii; Sandra B M Valarini; Aytan M Sipahi
Journal:  World J Gastroenterol       Date:  2006-10-28       Impact factor: 5.742

10.  Different features of coeliac disease in two neighbouring countries.

Authors:  H Ascher; K Holm; B Kristiansson; M Mäki
Journal:  Arch Dis Child       Date:  1993-09       Impact factor: 3.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.